BCIIX
Price
$16.72
Change
-$0.00 (-0.00%)
Updated
Dec 24 closing price
Net Assets
61.99M
RERAX
Price
$56.08
Change
-$0.04 (-0.07%)
Updated
Dec 24 closing price
Net Assets
134.15B
Interact to see
Advertisement

BCIIX vs RERAX

Header iconBCIIX vs RERAX Comparison
Open Charts BCIIX vs RERAXBanner chart's image
Brown Capital Mgmt Intl All Com I
Price$16.72
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets61.99M
American Funds EUPAC R1
Price$56.08
Change-$0.04 (-0.07%)
VolumeN/A
Net Assets134.15B
BCIIX vs RERAX Comparison Chart in %
View a ticker or compare two or three
VS
BCIIX vs. RERAX commentary
Dec 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCIIX is a StrongBuy and RERAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 134B vs. BCIIX (62M). RERAX pays higher dividends than BCIIX: RERAX (0.22) vs BCIIX (0.00). BCIIX was incepted earlier than RERAX: BCIIX (27 years) vs RERAX (24 years). BCIIX (1.95) is less costly to investors than RERAX (1.57). BCIIX is a more actively managed with annual turnover of: 56.00 vs. RERAX (35.00). RERAX has a lower initial minimum investment than BCIIX: RERAX (250) vs BCIIX (5000). RERAX annual gain was more profitable for investors over the last year : 9.94 vs. BCIIX (-0.95). BCIIX return over 5 years is better than : -5.71 vs. RERAX (-11.51).
BCIIXRERAXBCIIX / RERAX
Total Expense Ratio1.251.5780%
Annual Report Gross Expense Ratio1.951.57124%
Fund Existence27 years24 years-
Gain YTD0.42011.2044%
Front LoadN/AN/A-
Min. Initial Investment50002502,000%
Min. Initial Investment IRAN/AN/A-
Net Assets62M134B0%
Annual Yield % from dividends0.000.22-
Returns for 1 year-0.959.94-10%
Returns for 3 years29.3123.04127%
Returns for 5 years-5.71-11.5150%
Returns for 10 years38.1130.17126%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KAJMF35.20N/A
N/A
Kajima Corp.
VICP1.50N/A
N/A
Vicapsys Life Sciences, Inc.
MCVEF27.25N/A
N/A
Medicover AB
BSLAF16.16N/A
N/A
Basler Ag
LINMF0.03N/A
-4.71%
LINEAR MINERALS CORP.